AbbVie Inc. (ABBV)
NYSE: ABBV
· Real-Time Price · USD
206.36
1.68 (0.82%)
At close: Aug 15, 2025, 3:42 PM
AbbVie Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 1.29B | 4.29B | 1.59B | 1.37B | 1.36B | 826M | 1.78B | 2.03B | 241M | 2.47B | 3.95B | 928M | 4.49B | 4.04B | 3.18B | 769M | 3.56B |
Depreciation & Amortization | 2.04B | 2.1B | 2.08B | 2.13B | 2.07B | 2.08B | 2.23B | 2.26B | 2.13B | 2.16B | 2.21B | 2.05B | 2.05B | 1.98B | 2.13B | 2.2B | 2.21B |
Stock-Based Compensation | 410M | 674M | 181M | 218M | 348M | 125M | 130M | 179M | 313M | 132M | 126M | 107M | 306M | 129M | 135M | 159M | 269M |
Other Working Capital | -250M | -1.9B | 203M | -1.81B | 662M | -171M | 142M | -667M | 20M | 154M | 220M | -249M | 153M | -397M | -247M | -704M | -139M |
Other Non-Cash Items | 505M | 1.15B | 1.12B | 1.95B | 388M | 2.68B | 1.66B | 1.67B | 2.6B | 2.34B | 602M | 3.68B | -475M | 751M | 819M | 2.84B | -178M |
Deferred Income Tax | -28M | -767M | -277M | -16M | -389M | -1.39B | -863M | -368M | -267M | -516M | -621M | -600M | -194M | -745M | -34M | -91M | -28M |
Change in Working Capital | -2.58B | -397M | 750M | -3.38B | 247M | 443M | 2.64B | 554M | -825M | 843M | 1.34B | -1.16B | -1.27B | -1.08B | 1.71B | -990M | -956M |
Operating Cash Flow | 1.64B | 7.05B | 5.45B | 2.27B | 4.04B | 4.75B | 7.57B | 6.32B | 4.19B | 7.43B | 7.6B | 5B | 4.91B | 5.08B | 7.93B | 4.89B | 4.88B |
Capital Expenditures | -235M | -291M | -249M | -241M | -193M | -205M | -219M | -178M | -175M | -213M | -177M | -143M | -162M | -187M | -217M | -195M | -188M |
Cash Acquisitions | -538M | -1.79B | -8.29B | -843M | -9.39B | -553M | -157M | -160M | -353M | -300M | -100M | -209M | -185M | -1.06B | -492M | -147M | -198M |
Purchase of Investments | -10M | -27M | -24M | -16M | -6M | -34M | -8M | -16M | -19M | -10M | -17M | -5M | -1.41B | -46M | -17M | -40M | -16M |
Sales Maturities Of Investments | 32M | 39M | 507M | 3M | 6M | 14M | 5M | 14M | 22M | 70M | 1.41B | 42M | 8M | 10M | 23M | 54M | 11M |
Other Investing Acitivies | 16M | 197M | -196M | -5M | -6M | -22M | 10M | -1M | 26M | 5M | 170M | 445M | 154M | 143M | 88M | 86M | 49M |
Investing Cash Flow | -735M | -1.87B | -8.26B | -1.1B | -9.59B | -800M | -369M | -341M | -499M | -448M | 1.29B | 130M | -1.59B | -1.15B | -615M | -242M | -342M |
Debt Repayment | 2.56B | -3.76B | -403M | -3.35B | 14.86B | -1.79B | -2M | -1B | -1.35B | -6.85B | -2.7B | -2M | -2.88B | -3.75B | -1.2B | -3.46B | n/a |
Common Stock Repurchased | -961M | -358M | -17M | -9M | -1.32B | -3M | -4M | -10M | -1.96B | -4M | -4M | -9M | -1.47B | -131M | -6M | -10M | -787M |
Dividend Paid | -2.92B | -2.75B | -2.75B | -2.75B | -2.77B | -2.63B | -2.63B | -2.63B | -2.66B | -2.51B | -2.5B | -2.51B | -2.53B | -2.31B | -2.31B | -2.31B | -2.32B |
Other Financial Acitivies | 67M | 11M | 99M | 10M | 52M | -26M | -28M | -283M | -225M | -273M | -309M | -161M | -97M | -141M | -121M | -103M | -65M |
Financial Cash Flow | -1.26B | -6.86B | -3.07B | -6.1B | 10.82B | -4.45B | -2.66B | -3.92B | -6.19B | -9.63B | -5.52B | -2.68B | -6.97B | -6.34B | -3.64B | -5.88B | -3.17B |
Net Cash Flow | -349M | -1.73B | -5.87B | -4.94B | 5.25B | -473M | 4.53B | 2.05B | -2.49B | -2.63B | 3.31B | 2.42B | -3.65B | -2.44B | 3.64B | -1.21B | 1.31B |
Free Cash Flow | 1.4B | 6.76B | 5.2B | 2.03B | 3.85B | 4.55B | 7.36B | 6.14B | 4.02B | 7.21B | 7.42B | 4.86B | 4.75B | 4.89B | 7.72B | 4.7B | 4.69B |